Recurrence of Bleeding in Patients with Hypertensive Intracerebral Hemorrhage

Abstract

To characterize the recurrence of bleeding in patients who had hypertensive intracerebral hemorrhage (HICH), the authors reviewed 989 patients who underwent treatment for HICH between 1989 and 1995. Fifty-three patients (5.4&percnt;) had two episodes of HICH within a median interval of 22.9 ± 16.3 months (range 1.5-72 months), and of these 3 (5.7&percnt;) had three episodes of HICH. The recurrence of bleeding most commonly occurred within 2 years of the first hemorrhage: in 66&percnt; of the 53 patients the second hemorrhage occurred soon after the first (within 1 year in 34&percnt;, within 1-2 years in 32.1&percnt;). The site of the second hemorrhage was different from the initial site in all patients. Only 1 patient had a third hemorrhage in the same site as the second hemorrhage. The common patterns of recurrence were ‘ganglionic (putamen/caudate nucleus)-thalamic’ in 26.8&percnt; and ‘ganglionic-ganglionic’ in 21.4&percnt;. The ‘lobar-lobar’ pattern was noted in only 2 patients. The volume of the hematoma was increased at the second hemorrhage. The overall mortality was 28.3&percnt;. The risk of recurrent hemorrhage significantly increased in the patients who had antihypertensive therapy of less than 3 months after the initial attack compared to those with further long-term therapy (p < 0.005). Long-term regular control for hypertension is needed to prevent recurrent hemorrhage.